Orchard Therapeutics plc Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2018 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Orchard Therapeutics plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2018 to Q3 2023.
  • Orchard Therapeutics plc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $2.47M, a 28.8% decline year-over-year.
  • Orchard Therapeutics plc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $12.5M, a 28.3% decline year-over-year.
  • Orchard Therapeutics plc annual Share-based Payment Arrangement, Expense for 2022 was $16M, a 29% decline from 2021.
  • Orchard Therapeutics plc annual Share-based Payment Arrangement, Expense for 2021 was $22.5M, a 19.4% decline from 2020.
  • Orchard Therapeutics plc annual Share-based Payment Arrangement, Expense for 2020 was $28M, a 44% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $12.5M $2.47M -$1M -28.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $13.5M $2.58M -$1.38M -34.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $14.9M $3.51M -$1.15M -24.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $16M $3.93M -$1.41M -26.5% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-14
Q3 2022 $17.4M $3.47M -$1.92M -35.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $19.3M $3.96M -$1.59M -28.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $20.9M $4.66M -$1.61M -25.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $22.5M $5.34M -$1.4M -20.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 $23.9M $5.39M -$274K -4.84% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $24.2M $5.54M -$538K -8.85% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $24.8M $6.27M -$3.21M -33.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $28M $6.74M +$1.07M +18.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $26.9M $5.66M +$361K +6.81% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $26.5M $6.08M +$1.45M +31.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $25.1M $9.48M +$5.66M +148% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $19.4M $5.67M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 $5.3M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 $4.63M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $3.82M +$2.72M +246% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $1.1M Jan 1, 2018 Mar 31, 2018 6-K 2019-05-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.